Astera Labs, Inc.【ALAB】

Market cap

$19.8B

P/E ratio

	Dec 31, 2024
Net loss	-83
Stock-based compensation	235
Depreciation	3
Non-cash operating lease expense	2
Warrants contra revenue	1
Inventory Write-down	0
Accretion of discounts on marketable securities and other	8
Accounts receivable, net	30
Inventory	19
Prepaid expenses and other assets	13
Accounts payable	21
Accrued expenses and other liabilities	31
Operating lease liability	-2
Net cash provided by (used in) operating activities	137
Purchases of property and equipment	34
Purchases of marketable securities	931
Sales and maturities of marketable securities	209
Other investing activities	1
Net cash used in investing activities	-758
Proceeds from Issuance Initial Public Offering	672
Payment of deferred offering costs	5
Proceeds from Stock Options Exercised	5
Proceeds from employee stock purchase plan	4
Tax withholding related to net share settlements of restricted stock units	20
Repurchase of common stock upon termination	1
Net cash provided by (used in) financing activities	656
Net increase (decrease) in cash, cash equivalents, and restricted cash	35
Conversion of Stock, Amount Issued	255
Income taxes paid	8